---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-028595"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2024-07-22T23:59:59+00:00"
generated_at: "2026-05-31T18:37:23.929238+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma replaces auditor KMJ Corbin with Crowe LLP after KMJ partners join Crowe

## Summary
- Effective July 17, 2024, Immix dismissed KMJ Corbin & Company LLP and appointed Crowe LLP as its independent registered public accounting firm.
- Change follows the partners and professional staff of KMJ joining Crowe; no disagreements or reportable events in fiscal 2022 or 2023.
- KMJ's audit reports for the two most recent fiscal years were unqualified and contained no adverse or modified opinions.
- KMJ provided a letter agreeing with the dismissal statements, filed as Exhibit 16.1 to this Form 8-K.

## SEC filing metadata
- accession: 0001493152-24-028595
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2024-07-22T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/0001493152-24-028595-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315224028595/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-028595
- JSON: https://secwatch.observer/filing/0001493152-24-028595.json
- Plain text: https://secwatch.observer/filing/0001493152-24-028595.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.